Golimumab for the Treatment of Axial Spondyloarthritis: Integrating Clinical Outcomes with Real-World Patient Benefits.

Deodhar A, Kim TJ, Navarro-Compán V, Fonseca S, Antunes J, Singh A, Milek R, Wu J, Ramiro S.

Open source

DOI
10.1007/s12325-026-03742-w
Published
2026-08-10
Container
Adv Ther
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12325-026-03742-w,
  title = {Golimumab for the Treatment of Axial Spondyloarthritis: Integrating Clinical Outcomes with Real-World Patient Benefits.},
  author = {Deodhar A and  Kim TJ and  Navarro-Compán V and  Fonseca S and  Antunes J and  Singh A and  Milek R and  Wu J and  Ramiro S.},
  year = {2026},
  journal = {Adv Ther},
  doi = {10.1007/s12325-026-03742-w},
  url = {https://doi.org/10.1007/s12325-026-03742-w}
}

RIS

TY  - JOUR
TI  - Golimumab for the Treatment of Axial Spondyloarthritis: Integrating Clinical Outcomes with Real-World Patient Benefits.
AU  - Deodhar A
AU  -  Kim TJ
AU  -  Navarro-Compán V
AU  -  Fonseca S
AU  -  Antunes J
AU  -  Singh A
AU  -  Milek R
AU  -  Wu J
AU  -  Ramiro S.
PY  - 2026
JO  - Adv Ther
DO  - 10.1007/s12325-026-03742-w
UR  - https://doi.org/10.1007/s12325-026-03742-w
ER  - 

APA

A, D., TJ, K., V, N., S, F., J, A., A, S., R, M., J, W., & S., R. (2026). Golimumab for the Treatment of Axial Spondyloarthritis: Integrating Clinical Outcomes with Real-World Patient Benefits.. Adv Ther. https://doi.org/10.1007/s12325-026-03742-w

Source records